Results 41 to 50 of about 2,881,713 (137)

Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays

Journal of Health Sciences, 2016
Introduction: In the present study we investigated the performance, precision, and recovery of three different automated methods in determining cancer antigen (CA) 15-3 levels. Methods: Serum samples were obtained from 60 hospitalized female patients. As
Nafija Serdarevic, Raif Serdarevic, Amra Memic   +2 more
doaj   +1 more source

Exploring the Significance of Cluster Analysis on Time-Series Measurement of Plasma Cancer Antigen 15-3 in a Patient with Metastatic Breast Cancer

Applied Medical Informatics
Cancer Antigen 15-3 (CA 15-3) is a glycoprotein often linked to breast cancer. Elevated levels of CA 15-3, above the normal reference range of 30 U/mL (units per milliliter), are frequently found in the blood of patients with metastatic breast cancer ...
Alexandros CLOUVAS
doaj  

Serum CA 549, CA 19-9, CA 15-3, and CEA Levels in Patients With Breast Cancer

Eurasian Journal of Medicine, 2019
-
Mahmut C. Başoğlu, Sabri Selçuk Atamanalp, M. İlhan Yıldırgan, Cafer Polat, Leyla Yıldız, K.Yalçın Polat, M.Sait Keleş, Sevinç Kuşkay   +7 more
doaj  

Serum biomarkers (CA 15-3, CEA) and hormonal receptor status as predictors of breast cancer recurrence

Mìžnarodnij Endokrinologìčnij Žurnal
Background. Breast cancer is a heterogenous malignancy and is one of the leading causes of cancer-related mortality in women worldwide. Recurrence as a barrier to long-term survivorship and effective patient management is a formidable challenge.
Muntaha Maddah Al Alouci, Fatima Mallallah Mohammed, Zainab M. Qassam, Osama A. Mohsein   +3 more
doaj   +1 more source

Serum miR-16 and CA15.3 combination as early diagnostic biomarkers for breast cancer in Egyptian females [PDF]

Egyptian Journal of Pure and Applied Science
Background: Breast cancer (BC) represents one of the most lethal malignancies among women worldwide. MiRNAs play an important role in breast cancer diagnosis and progression. Inconsistent data about the expression level of miR-16 was reported in BC, thus
Sara Kamal, Doaa Ibrahim, Reham Elshimy, Walid Zahran   +3 more
doaj   +1 more source

Serum NSE, CEA, CT, CA 15-3 Levels in Human Lung Cancer

The International Journal of Biological Markers, 1990
The significance of neuron specific enolase (NSE) was investigated in comparison with other tumor markers (CEA, CT, CA 15-3) used in the diagnosis and treatment monitoring of lung cancer.
S. Nutini, G. Cappelli, A. Benucci, C. Catalani, F. Nozzoli   +4 more
doaj   +1 more source

CA 15-3, CRP, and LDH correlates with prognostic parameters in canine mammary neoplasms. [PDF]

Anim Reprod, 2023
Pinheiro BQ, de Magalhães FF, Alves FWDS, Silva ING, Faustino AMR, da Silva LDM.   +5 more
europepmc   +1 more source

Time Series measurements of White Blood Cells (WBC) and plasma Cancer Antigen 15-3 (CA 15-3) in a patient with metastatic breast cancer, serving as a reference for assessing the clinical relevance of different clustering algorithms.

Applied Medical Informatics
Clustering is highly valuable for analyzing cancer marker time series data. In a recent study, the significance of the K-means clustering algorithm was examined for the first time in evaluating time-series measurements of plasma Cancer Antigen 15-3 (CA ...
Alexandros CLOUVAS
doaj  

Prognostic Significance of CRP and CA 15-3 Levels in the Diagnosis of Breast Cancer: A Comparative Study

Russian Open Medical Journal
Background — C-reactive protein (CRP) and cancer antigen 15-3 (CA 15-3) are commonly studied biomarkers in breast cancer, but their prognostic significance at diagnosis remains unclear. Aim: Our study aimed to assess the prognostic value of serum CRP and
Zein Al-Abideen Douba, Rama Ibrahim
doaj   +1 more source

Correction: Novel sensor for the determination of CA 15-3 in serum of breast cancer patients based on Fe-gallic acid complex doped in modified cellulose polymer thin films. [PDF]

RSC Adv, 2023
AlGhamdi HA, AlZahrani YM, Alharthi S, Mohy-Eldin MS, Mohamed EH, Sheta SM, El-Sheikh SM, Mahmoud SA, Attia MS.   +8 more
europepmc   +1 more source